Future Care for Medical Industries (FCMI) results, Q1 2023
Net profit, assets, equity and cash flow for Q1 2023, against the same period a year earlier, from the published financial statements.
Net profit127 thousandEGP · +242.9% vs the same period a year earlier
Total assets60.49 millionEGP · −4.8% vs the same period a year earlier
Shareholders' equity57.95 millionEGP · −2.9% vs the same period a year earlier
Operating cash flow1.01 millionEGP · +118.4% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q1 2023 was about 127 thousand EGP, up +242.9% from -88.62 thousand EGP in Q1 2022.
- Total assets at the end of Q1 2023 were about 60.49 million EGP, and shareholders' equity about 57.95 million EGP.
- Operating cash flow for Q1 2023 was positive at 1.01 million EGP.
Key lines against the same period a year earlier
This periodQ1 2022Change
Net profit127 thousand-88.62 thousand+242.9%
Gross profit1.56 million167 thousand+830.4%
Total assets60.49 million63.55 million−4.8%
Total liabilities2.54 million3.87 million−34.3%
Shareholders' equity57.95 million59.68 million−2.9%
Total liabilities and equity60.49 million63.55 million−4.8%
Operating cash flow1.01 million-5.49 million+118.4%
Investing cash flow—-1.53 thousand—
Financing cash flow-9.86 million-2.05 million−382.2%
Net change in cash-8.85 million-7.54 million−17.4%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy